首页> 外文OA文献 >Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology

【2h】

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology

机译：早期类风湿性关节炎患者的基线代谢型患者在启动治疗对靶对靶对巯基，甲氨蝶呤或组合后实现持续无药物缓解：来自系统生物学的见解

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Xavier M Teitsma; Wei Yang; Johannes W G Jacobs; Attila Pethö-Schramm; Michelle E A Borm; Amy C Harms; Thomas Hankemeier; Jacob M van Laar; Johannes W J Bijlsma; Floris P J G Lafeber;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology [J] . Xavier M Teitsma, Wei Yang, Johannes W G Jacobs, Arthritis research & therapy. . 2018,第1期

机译：早期类风湿关节炎患者的基线代谢特征在启动靶向治疗的tocilizumab，甲氨蝶呤或两者结合后达到持续的无药物缓解：来自系统生物学的见解
2. Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics [J] . Teitsma X. M., Jacobs J. W. G., Concepcion A. N., Clinical and experimental rheumatology . 2018,第6期

机译：促进蛋白质生物标志物患者早期类风湿性关节炎治疗持续无药物缓解治疗后的蛋白质生物标志物 - 基于甲氨蝶呤 - 或甲氨蝶呤的策略：从转录组织到蛋白质组学
3. Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy [J] . Xavier M. Teitsma, Johannes W. G. Jacobs, Michal Mokry, Arthritis research & therapy. . 2017,第1期

机译：鉴定类风湿关节炎中共表达的差异基因网络，采用基于托珠单抗或甲氨蝶呤的策略治疗后可实现持续无药缓解
4. Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab methotrexate or the combination: insights from systems biology [O] . Xavier M Teitsma, Wei Yang, Johannes W G Jacobs, 2018

机译：早期类风湿关节炎患者的基线代谢特征在开始靶向治疗的tocilizumab甲氨蝶呤或两者结合后达到持续的无药物缓解：来自系统生物学的见解
5. On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis [O] . Vivian P. Bykerk, Gerd R. Burmester, Bernard G. Combe, 2018

机译：基线症状持续时间的药物和无药物缓解：患有早期类风湿性关节炎患者的甲氨蝶呤癫痫症

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology

著录项

引文网络

相似文献

相关主题

期刊订阅